What is the treatment for croup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Croup in Pediatric Patients

First-Line Treatment for All Severity Levels

All children with croup should receive oral dexamethasone 0.15-0.6 mg/kg (maximum 10-12 mg) as a single dose, regardless of severity. 1, 2 This recommendation is based on clear evidence that corticosteroids decrease symptoms, reduce hospitalization rates, and have minimal adverse effects with a single dose. 3

  • Oral administration is the preferred route over intramuscular injection 4
  • The 0.15 mg/kg dose appears equally effective as the higher 0.6 mg/kg dose 3
  • Nebulized budesonide 2 mg is an alternative when oral administration is not feasible and has equivalent efficacy to oral dexamethasone 1, 3

Severity-Based Treatment Algorithm

Mild Croup

  • Administer oral dexamethasone alone 1
  • Observe for 2-3 hours to ensure symptoms are improving 5
  • No nebulized treatments are needed 5

Moderate to Severe Croup

  • Administer oral dexamethasone PLUS nebulized epinephrine 1, 2
  • Nebulized epinephrine dose: 0.5 ml/kg of 1:1000 solution (maximum 5 ml) 1, 5
  • Provide supplemental oxygen to maintain saturation ≥94% 1, 6
  • Observe for at least 2 hours after the last epinephrine dose to monitor for rebound symptoms 5, 7

Updated Hospitalization Criteria

Consider hospitalization only after 3 doses of nebulized epinephrine rather than the traditional 2 doses. 8, 1 This updated approach reduces hospitalization rates by 37% without increasing revisits or readmissions. 8, 1

Additional admission criteria include:

  • Oxygen saturation <92% 1
  • Age <18 months 1
  • Respiratory rate >70 breaths/min 1
  • Persistent difficulty breathing despite treatment 1
  • Persistent stridor at rest despite treatment 5

Critical Pitfalls to Avoid

  • Never discharge patients within 2 hours of receiving nebulized epinephrine due to the risk of rebound airway obstruction, as epinephrine effects last only 1-2 hours 5, 7
  • Do not use nebulized epinephrine in outpatient settings where adequate observation cannot be provided 1, 5
  • Do not admit after only 1-2 doses of epinephrine when a third dose could be safely administered in the emergency department with appropriate observation 1
  • Avoid failing to administer corticosteroids even in mild cases 5
  • Do not routinely use antibiotics, as croup is viral in etiology 2
  • Avoid relying on humidified air or mist therapy, which lack evidence of benefit 2, 4

Discharge Criteria

Patients may be discharged when they demonstrate:

  • Resolution of stridor at rest 1, 5
  • Minimal or no respiratory distress 1, 5
  • Adequate oral intake 1, 5
  • Parents understand warning signs and when to return 1, 5

When Standard Treatment Fails

If a patient fails to respond after 3 doses of racemic epinephrine, consider alternative diagnoses including bacterial tracheitis, foreign body aspiration, epiglottitis, peritonsillar abscess, or retropharyngeal abscess. 6, 2 Direct laryngoscopy and bronchoscopy should be performed to visualize the airway and identify alternative pathology. 6

References

Guideline

Treatment of Croup in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Croup: an overview.

American family physician, 2011

Research

Current pharmacological options in the treatment of croup.

Expert opinion on pharmacotherapy, 2005

Guideline

Treatment of Croup with Nebulization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Differentiating and Managing Croup versus Bacterial Tracheitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Croup.

The Journal of family practice, 1993

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.